Background: The positive predictive value (PPV) of the International Classification of Diseases, Ninth Revision—Clinical Modification (ICD-9-CM) code for “essential and other specified forms of tremor” in identifying essential tremor (ET) cases was found to be less than 50%. The ability of the ICD-10-CM G25.0 code for “essential tremor” to identify ET has not been determined. The study objective was to determine the PPV of the G25.0 code. Methods: Patients in a tertiary health system with a primary care encounter associated with ICD-10-CM code G25.0 in 2022 underwent medical record review to determine if the consensus criteria from the International Parkinson and Movement Disorder Society for an ET diagnosis were met. Results: 442 patients were included. The PPV of G25.0 in identifying probable ET cases was 74.7% (95% confidence interval (CI) 70.4–78.5%). Among patients prescribed propranolol, the PPV improved to 87.8% (95% CI 78.0–93.6%). Discussion: Compared to the ICD-9-CM code 333.1, G25.0 is superior for identifying ET cases. A potential limitation of this study is that the consensus criteria applied relies on nonspecific physical exam findings which may lead to an overestimation of the PPV of G25.0. Highlights: The ICD-10-CM diagnosis code for essential tremor has not been previously validated. The objective of this study was to determine the PPV of the G25.0 code. The PPV in identifying essential tremor cases was 74.7%. The PPV improved among patients prescribed propranolol.
14 October 2025 in Frontiers in Human Neuroscience
Over the past decade, deaths attributable to opioid and stimulant use have risen dramatically. While the U.S. Food and Drug Administration (FDA) has approved three medications for opioid use disorder, there is currently no FDA-approved treatment for stimulant use disorder. Despite the availability of medications for opioid use disorder, the rates of relapse and overdose, particularly in the time of widespread fentanyl use, remain distressingly high. There is an urgent need for more effective treatment options for these debilitating disorders. This article provides an overview of the current standard of care for opioid use disorder and stimulant use disorder. New and emerging neuromodulation approaches with a particular focus on deep brain stimulation are then discussed.
20 September 2021 in Surgical Neurology International
Background: Diversion of prescription opioids pills is a significant contributor to opioid misuse and the opioid epidemic. The goal of this study was to determine the frequency and quantity of excess opioid pills among patients undergoing spine surgery. Further, we wanted to determine the frequency of appropriate opioid disposal. Methods: This was a prospective cohort study of patients undergoing elective spine surgery within a multi-hospital, academic, urban university health system enrolled in a text-messaging program used to track postoperative opioid disposal. Patients who self-reported discontinuation of opioid use but with leftover pills were contacted via telephone and surveyed on opioid disposal. Results: Of the 291 patients who enrolled in the text-messaging program, 192 (66%) patients reported discontinuing opioids within 3 months of surgery. Although 76 (40%) reported excess opioid pills after cessation of use, only 47 (62%) participated in the telephone survey regarding opioid disposal. The median number of leftover pills among these 47 patients was 5 (5, 15) and 64% had not disposed of their prescription. Conclusion: Among the 47 telephone survey participants, a persistent gap remained in postoperative opioid excess and improper disposal. Future efforts must focus on initiatives to improve opioid disposal rates to reduce the quantity of opioids at risk for diversion and to reduce excess prescribing.
A 57-year-old female with eight years of hemifacial spasm (HFS) underwent endoscopic microvascular decompression (MVD) of the facial nerve. Baseline stimulation of the zygomatic branch of the facial nerve activated at 1.2 mA. Lateral spread response (LSR) to the buccal and mandibular branches was observed at 2.2 mA. A straight endoscope was used to enter the cerebellopontine angle, allowing for visualization of the vestibulocochlear and facial nerve. Neurovascular compression was not clearly identified. A 30-degree endoscope was directed medially/inferiorly and compression at the root entry zone was identified and decompressed. Subsequent LSR to the buccal/mandibular branches was seen at 3.2 mA/3.6 mA, respectively. Additional vascular compression was suspected given persistent LSR. The 30-degree endoscope was directed laterally. Compression was seen at the porus acustics and decompressed. Subsequent LSR to the buccal/mandibular branches was not observed until 9.8 mA, indicating good decompression. The patient tolerated the procedure well with complete resolution of her symptoms and remains spasm-free as of three months post-procedure without a hearing deficit. The 30-degree endoscope enabled visualization of pathology that was not easily seen at 0-degree. Additionally, LSR indicated persistent nerve compression following root entry zone decompression. Subsequent distal decompression resulted in greater LSR reduction. This case report suggests that MVD for HFS may yield better results with both proximal and distal decompression of the seventh nerve, and this type of decompression can benefit from endoscopic visualization.